Minor injury: 24 weeks at 250500 mcg/day Severe injury or surgery: 46 weeks, up to 1,000 mcg/day Gut repair: 46 weeks oral or SubQ Neurological support: 48 weeks Most patients notice improvements within 710 days, especially in pain reduction and mobility
Prolonged treatment in premature neonates may result in toxic levels of aluminum
For individuals with BMI above 30 or BMI above 27 with comorbidities, FDA-approved GLP-1 receptor agonists (semaglutide, tirzepatide) have far stronger evidence and produce dramatically greater weight loss
Lower risk of severe side effects : Compared to other weight loss medications, Mounjaro tends to have a favorable safety profile, with fewer reports of severe gastrointestinal side effects than some other injectable GLP-1-based drugs
Hydration Therapy ($99) and Energy Boost ($155) for everyday reset, Immune Boost ($215) in cold-and-flu season, and NAD+ IV therapy (from $160) for focus and energy